The extraordinary promise of personalised cancer vaccines
Ian Sample talks to Prof Alan Melcher of the Institute of Cancer Research about how personalised cancer vaccines work and whether they could one day be used to to target cancer before it is even detectable on scans
May 2, 202413m 15s
Audio is streamed directly from the publisher (flex.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Glioblastomas are an extremely aggressive type of brain tumour, which is why the news this week of a vaccine that has shown promise in fighting them is so exciting. And this comes right off the back of the announcement of another trial of the world’s first personalised mRNA vaccine for melanoma, a kind of skin cancer. Ian Sample talks to Prof Alan Melcher of the Institute of Cancer Research about how these vaccines work and whether they could one day be used to target cancer before it is even detectable on scans. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>
Topics
ScienceCancer researchSkin cancerMedical researchSocietyVaccines and immunisationHealthCancer